Navigation Links
Mild HIV type slows development of AIDS and makes new preventive treatments possible
Date:7/19/2012

A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.

The findings have just been published in the distinguished scientific journal New England Journal of Medicine.

The most common type of the virus that causes AIDS HIV-1 is less aggressive when it infects a person already carrying the milder HIV-2. The study looked at how the disease developed in those who had been infected with HIV-1 and those who were infected with both HIV-1 and HIV-2.

"The moderating effect of HIV-2 was extremely strong. The time it took to develop AIDS was around 50 per cent longer for those infected with both strains than for those only carrying the HIV-1 virus. The unusually large difference makes me, as a researcher, very optimistic that it will be possible to identify new and significant approaches that can be taken to combating the development of AIDS", says Joakim Esbjrnsson, a virologist at Lund University.

"The unique thing about our study, which has been carried out over 20 years, is that we have been able to follow healthy individuals from when they were infected with HIV-1 only or both HIV-1 and HIV-2 through the entire course of the disease, and to make comparisons of how the infection has developed over time", says Hans Norrgren, doctor in infectious diseases and researcher at Lund University and Skne University Hospital.

An observation that was linked to an early stage of HIV infection was a difference in the genetic diversity of the HIV. It is well-known that different strains of HIV co-exist during the course of the infection and that the genetic difference between them increases the closer to AIDS the infection comes. This genetic difference was lower early on in the disease among people with a dual infection than among those with only HIV-1 infection, which gave them a better starting point from which the development of AIDS was delayed.

The researchers have also studied the levels of CD4+ T cells helper cells with a key role in the immune system that are attacked and destroyed by the HIV virus. Patients with dual infection were also seen to be at an advantage in this. They had a higher number of CD4+ T cells throughout the period of infection. It took longer to reach critically low levels of CD4+ T cells, and thus also longer before the infection developed into AIDS.

"Our results suggest that HIV-2 can activate cellular reactions which naturally check the development of AIDS. If we can map these, I think we can also uncover entirely new mechanisms that are key to the slower development of the disease. In the long run, this could lead to better preventive measures and treatments", says Patrik Medstrand, Professor of Virology at Lund University.

Behind the findings lies a unique 20-year follow-up of 4 700 people in Guinea-Bissau in West Africa.

"Our work is the result of many people's work over many years, in particular the staff of the National Public Health Laboratory in Guinea-Bissau and the police health station in the capital Bissau, who have carried out the practical work of examining the study participants, taking samples and conducting laboratory analyses", says Fredrik Mnsson, a doctor in infectious diseases in Malm and one of the researchers behind the study.


'/>"/>

Contact: Joakim Esbjornsson
46-703-993-802
Lund University
Source:Eurekalert

Related medicine news :

1. Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says
2. Infection With 2 HIV Strains Slows Disease Progression
3. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
4. Kudos for 3 NJIT Enterprise Development Center high-tech companies
5. 2 repressor genes identified as essential for placental development
6. Louisiana Tech University professor earns NSF Early Career Development grant
7. Advanced genetic screening method may speed vaccine development
8. New biospecimens management system in development
9. Developmental Woes Common in Siblings of Children With Autism
10. Mutations impair childhood growth and development by disrupting organization of chromosome pairs
11. Penn and Cornell researchers spearhead the development of new guidelines for veterinary CPR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: